About
Pipeline & Research
NEWS & MEDIA
Investors
Careers
Contact Us

Select Page

BeyondSpring Second-Quarter 2020 Financial Results and Business Updates

November 23, 2020

09.03.2020

BeyondSpring Second-Quarter 2020 Financial Results and Business Updates

Search for:

RECENT NEWS ARTICLES

BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021
BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium
BeyondSpring to Present at Two Upcoming Scientific Conferences in December
BeyondSpring to Participate in Upcoming Evercore ISI 2020 Conference
BeyondSpring Announces Pricing of Ordinary Shares
BeyondSpring Announces Proposed Public Offering of Ordinary Shares
BeyondSpring Announces Third Quarter 2020 Financial Results and Provides Business Updates
BeyondSpring Announces Positive Topline Results from its PROTECTIVE-2 Phase 3 Registrational Trial of Plinabulin in Combination with Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia

RECENT MEDIA COVERAGE

New Treatment Modalities: Protein Degraders And Molecular Glues Gain Traction
Seed Therapeutics blossoms in an $800M deal with Lilly
Seed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer
BeyondSpring Forms Partnership Advisory Committee Comprised of Industry Veterans
JAMA Oncology Highlights Plinabulin’s Efficacy in Preventing Chemotherapy-Induced Neutropenia as a Monotherapy
Pegfilgrastim Plus Plinabulin Reduces Chemo-Induced Neutropenia in TAC-Treated Patients
Dr. Lan Huang Featured in Nature Titled “‘Innovation’ Nation”
Woman of the Week Podcast: Dr. Lan Huang, Co-founder, Chairman and Chief Executive Officer BeyondSpring
Developing Triple-Combination Immunotherapies: Lessons Learned From HIV
Meet BeyondSpring: A Fly exclusive interview with CEO Lan Huang

WORK WITH US

LifeSci Advisors

Investor Contact
Ashley R. Robinson
+1 617-430-7577
arr@lifesciadvisors.com

Media Contact
Darren Opland, Ph.D.
+1 646-627-8387
darren@lifescicomms.com

BeyondSpring Inc.
+1 (646) 305-6387
general@beyondspringpharma.com

GET UPDATES

Subscribe to BeyondSpring News & Media!

Who We Are
Management Team
Scientific Advisors
Board of Directors

PIPELINE & RESEARCH

Pipeline Overview
Plinabulin
Protein Degradation
Other Pipeline
Posters & Publications
Collaboration
Expanded Access Policy

Stock Overview
Events & Presentations
Financials & Filings
Corporate Governance

Job Opportunities

NEWS & MEDIA

Press Releases
Media Coverage

BeyondSprings Inc LinkedIn

BeyondSprings Inc Twitter

©2021 BeyondSpring Inc. All rights reserved. Privacy Notice | Terms of Use

We use cookies to ensure that we give you the best experience on our website. Please click “OK” to continue or read our Privacy & Cookie Policy.Ok Privacy policy